1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
P30: Center Core Grant - NIDDK Center Core Grants (P30) support shared resources and facilities for use by multiple investigators to enhance multidisciplinary approaches and collaborative research efforts focused on a common research problem or goal. The core grant is utilized by independently funded research projects.
NIDDK currently uses the P30 mechanism to fund centers in cystic fibrosis, diabetes, digestive diseases, kidney disease, molecular hematology, and nutrition and obesity. Details for each center type are below as well as links to the current Request for Applications (RFA) when available.
Cystic Fibrosis Research and Translation Centers Cystic Fibrosis Research and Translation Core Centers are designed to support both basic and clinical research on Cystic Fibrosis. Cystic Fibrosis Research and Translation Core Centers support three primary research-related activities: Research Core services; a Pilot and Feasibility program; and an Administrative Core with an enrichment program.
Core Centers provide shared resources to support research to develop and test new therapies for Cystic Fibrosis and to foster collaborations among institutions with a strong existing research base in Cystic Fibrosis.
For more information, view the Cystic Fibrosis Research and Translation Centers page Current RFA: RFA-DK-25-010 NIDDK supports two types of diabetes centers: Diabetes Research Centers, and Centers for Diabetes Translation Research. An existing base of high quality diabetes-related research is a primary requirement for establishment of a center.
While not directly funding major research projects, all center grants provide core resources to integrate, coordinate, and foster the interdisciplinary cooperation of a group of established investigators conducting research in diabetes and related areas of endocrinology and metabolism.
For more information view the Diabetes Centers page Application Resources (Diabetes Research Centers; DRCs) Application Resources (Centers for Diabetes Translation Research; CDTRs) Digestive Diseases Research Core Centers Digestive Diseases Research Core Centers support shared resources that facilitate impactful interdisciplinary cooperation between established investigators with research programs aligned with a common research focus or theme related to digestive and/or liver disease within the mission of the NIDDK.
An existing base of high-quality digestive and/or liver disease-related research is a prerequisite for the establishment of a Center. Individual Centers include biomedical research cores, an administrative Core, a pilot and feasibility program, and an enrichment program.
A Center’s research focus should be cohesive and well-articulated to ensure a Center with components that will substantially advance a defined area of NIDDK-related research. Themes of the currently supported Centers and other additional information can be found on the research program page below.
For more information view the Digestive Diseases Research Core Centers page Due to a restriction on the number of core center grants that can be supported, new center grant proposals will be accepted only in response to a Request for Applications (RFA) as periodically announced in the NIH Guide for Grants and Contracts .
See the most recent Digestive Diseases Research Core Centers RFA View the Current Schedule of Review to see future opportunities O'Brien and Polycystic Kidney Disease Centers O'Brien Centers conduct interdisciplinary investigations that address basic, clinical, and applied aspects of biomedical research in renal physiology and pathophysiology.
Kidney diseases of hypertension and diabetes, immune- and nonimmune-related mechanisms of kidney disease, nephrotoxins and cell injury are emphasized. The O'Brien Centers are committed to sharing resources widely throughout the kidney community.
Polycystic Kidney Disease (PKD) Centers are part of an integrated program of research established to promote multidisciplinary interactions and to provide shared resources needed to address complex biomedical problems in this area, such as therapy of PKD. Kidney Centers Research Program O'Brien RFAs are issued every 5 years. See the most recent O'Brien RFA , issued in 2011.
PKD RFAs are issued every 5 years. See the most recent PKD RFA , issued in 2014 Administrative Guidelines (Tables) For Centers For PKD Research And Translation Core Centers (PDF, 7.
3 KB) Nutrition Obesity Research Centers The Nutrition Obesity Research Centers (NORC) Program is intended to integrate, coordinate, and foster interdisciplinary basic, clinical, translational, and public health research by a group of established investigators actively conducting programs of important, high-quality research that is related to research specific to NIDDK's mission.
NORCs are also intended to improve the quality and multidisciplinary nature of research in nutritional sciences and/or obesity by providing shared access to specialized technical resources and expertise. These centers provide increased, cost-effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in areas related to NIDDK's mission.
For more information view the Nutrition Obesity Research Centers page See the most recent NORC RFA , issued in 2016 Last Reviewed October 2024
According to the current listing, eligibility includes: Institutions with an existing base of high-quality research in the relevant focus area. Confirm the full requirements in the official notice before applying.
The current listing shows up to $750,000 direct costs per year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional) is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.